ecteinascidin 743 has been researched along with cribrostatin 4 in 2 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (cribrostatin 4) | Trials (cribrostatin 4) | Recent Studies (post-2010) (cribrostatin 4) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 8 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, C; Danishefsky, SJ; Wright, BJ | 1 |
| Wang, M; Yao, ZJ; Yu, BB | 1 |
2 other study(ies) available for ecteinascidin 743 and cribrostatin 4
| Article | Year |
|---|---|
Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
Topics: Antineoplastic Agents, Alkylating; Dioxoles; Drug Screening Assays, Antitumor; Female; Humans; Isoquinolines; Molecular Structure; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin | 2008 |
Simplified hybrids of two anticancer bistetrahydroisoquinoline alkaloids ecteinascidin 743 and cribrostatin 4 and inhibitory activity against proliferation of cancer cells.
Topics: Alkaloids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Molecular Structure; Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin | 2022 |